Benjamin Miron
Medical Director, Early Clinical Development at BMS | GU Medical Oncologist
- Role
- Director, Early Clinical Development at Bristol Myers Squibb
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Benjamin Miron
MD with special interest in emerging technologies and innovative therapeutics in the field of oncology.
Experience
Director, Early Clinical Development
Jan 2024 — Present · Princeton Pike, NJ, US
Lead early-stage oncology programs across a range of tumor types and treatment modalities. Oversee strategy and execution of first-in-human and proof-of-concept trials, working cross-functionally with research, regulatory, and clinical teams. Drive innovation through creative problem-solving and novel clinical trial design elements that accelerate development and address key challenges in oncology drug development.
Education
New York University
BA, Psychology
2003 — 2007
NYU Grossman School of Medicine
Doctor of Medicine (MD), with Honors in Immunology
2010 — 2014
Temple University
Bioinformatics
2022
Skills
- Clinical Trials
- Clinical Research
- Healthcare
- Medicine
- Research
- Neuroscience
- Lifesciences
- Science
- Infectious Diseases
- Molecular Biology
- Medical Devices
- Oncology
- Genetics
- Biostatistics
- Medical Research
- Cancer
- Hospitals
- Biotechnology
- Public Health
- Epidemiology
- Immunohistochemistry
- Data Analysis
- Psychiatry
- Clinical Development
- Due Diligence
- Biomedical Engineering
- Live Blogging
- Pharmaceutical Industry
- Immunology
- Healthcare Information Technology
- Medical Education
- Cancer Research
- Internal Medicine
- Global Health
- Irb
- Multi-Color Flow Cytometry
- Cell Culture
- Animal Models
- Pcr
- Cell Biology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.